Genprex is a gene therapy company developing treatments for cancer and diabetes. Its cancer therapies are based upon a technology platform, including its lead drug candidate, Oncoprex immunogene therapy, or Oncoprex, for non-small cell lung cancer that consists of a tumor suppressor gene inserted into a patient’s cells that has immunomodulatory effects.
|HQ||West Lake Hills, TX, US||Map|
Net income (FY, 2020)
EBIT (FY, 2020)
Market capitalization (22-Oct-2021)
Closing stock price (22-Oct-2021)
|USD||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020|
Depreciation and Amortization
Cash From Operating Activities
Genprex has 1.94k Twitter Followers. The number of followers has increased 0.2% month over month and increased 0.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Genprex founded?
Genprex was founded in 2009.
Who are Genprex key executives?
Genprex's key executives are Rodney Varner, Catherine M. Vaczy and Michael T. Redman.
How many employees does Genprex have?
Genprex has 8 employees.
Who are Genprex competitors?
Competitors of Genprex include Oragenics, NexImmune and Qu Biologics.
Where is Genprex headquarters?
Genprex headquarters is located at 3300 Bee Caves Rd 650 227, West Lake Hills.
Where are Genprex offices?
Genprex has offices in West Lake Hills and Austin.
How many offices does Genprex have?
Genprex has 2 offices.
Receive alerts for 300+ data fields across thousands of companies